Leap Therapeutics (LPTX) Misses Q3 EPS by 8c

Leap Therapeutics (NASDAQ: LPTX) reported Q3 EPS of ($0.08).

For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.

You May Also Be Interested In

• Freedom Broker Upgrades Element Solutions (ESI) to Buy, 'We would buy ESI aggressively on this news'
• Dollar General (DG) PT Raised to $140 at Telsey
• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM